General Information of the Compound
| Compound ID |
CP0034751
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(Z)-1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
(Z)-1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-en-1-one
1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one
1-(5-Pyridin-2-yl-oxazol-2-yl)-nonadec-10-en-2-one
2-Oleoyl-5-(2-pyridyl)oxazole
AKOS030561894
BDBM50157122
CHEMBL426230
SCHEMBL3193600
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H38N2O2
|
||||||||||||||||||
| Molecular Weight |
410.602
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCCC\C=C/CCCCCCCC(=O)c1ncc(o1)-c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H38N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-24(29)26-28-22-25(30-26)23-19-17-18-21-27-23/h9-10,17-19,21-22H,2-8,11-16,20H2,1H3/b10-9-
Show/Hide
|
||||||||||||||||||
| InChIKey |
MTEOAQVTLKPFRA-KTKRTIGZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Clinical Information about the Compound
Drug 1 ( 1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one )
| Drug Name | 1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one | ||
|---|---|---|---|